Literature DB >> 11251236

Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview study of patients living at home.

M Caap-Ahlgren1, O Dehlin.   

Abstract

The objectives of this study were to describe the prevalence of insomnia and depressive symptoms in patients with Parkinson's disease (PD) and to relate those symptoms to health-related quality of life. A total of 102 patients living at home, most of them moderately to severely disabled, were interviewed. Of them 43 patients were women with a mean age of 70 (range 58-79). The mean age for the men was 71 (range 56-80). Time since diagnosis was <2 years for 57%, 2-10 years for 31% and >10 years for 12%. The geriatric depression scale (GDS) and Livingston's insomnia scale were used. The results were related to quality of life as measured with the SF-36 health survey. The prevalence of insomnia was 80%. Moderate depressive symptoms were found in 47% and severe depressive symptoms in 5%. Patients with insomnia or with depressive symptoms had a significantly impaired quality of life on all eight scales of the SF-36. In a stepwise regression analysis the presence of pain and ache and depressive symptoms were significantly related to insomnia. The variables most related to depressive symptoms were Hoehn and Yahr group and insomnia. Hoehn and Yahr groups (more disability) were significantly related to insomnia and depressive symptoms. Thus, insomnia and depressive symptoms are prevalent in PD and influence quality of life and should, therefore, be considered when evaluating patients with PD.

Entities:  

Year:  2001        PMID: 11251236     DOI: 10.1016/s0167-4943(00)00087-x

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  20 in total

1.  Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.

Authors:  Simone Goebel; Elisabeth Steinmann; Bernd Leplow; H Maximilian Mehdorn
Journal:  Neurol Sci       Date:  2018-04-14       Impact factor: 3.307

2.  [What roll does the sense of coherence in coping with Morbus Parkinson play?].

Authors:  G Pusswald; M Fleck; D Haubenberger; E Auff; G Weber
Journal:  Z Gerontol Geriatr       Date:  2009-06-28       Impact factor: 1.281

Review 3.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 4.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease.

Authors:  Sonja Rutten; Chris Vriend; Ysbrand D van der Werf; Henk W Berendse; Daniel Weintraub; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2017-02-01       Impact factor: 4.891

Review 6.  Excessive daytime sleepiness in patients with Parkinson's disease.

Authors:  Bettina Knie; M Tanya Mitra; Kartik Logishetty; K Ray Chaudhuri
Journal:  CNS Drugs       Date:  2011-03       Impact factor: 5.749

7.  Feasibility of using cranial electrotherapy stimulation for pain in persons with Parkinson's disease.

Authors:  Diana H Rintala; Gabriel Tan; Pamela Willson; Mon S Bryant; Eugene C H Lai
Journal:  Parkinsons Dis       Date:  2010-05-05

8.  Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease.

Authors:  Shahrzad Mavandadi; Sarra Nazem; Thomas R Ten Have; Andrew D Siderowf; John E Duda; Matthew B Stern; Daniel Weintraub
Journal:  Am J Geriatr Psychiatry       Date:  2009-11       Impact factor: 4.105

Review 9.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

10.  Sleep disorders in Parkinson's disease.

Authors:  Israt Jahan; Robert A Hauser; Kelly L Sullivan; Amber Miller; Theresa A Zesiewicz
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.